Nrf2 is a critical modulator of the innate immune response in a model of uveitis

Norihiro Nagai, Rajesh K. Thimmulappa, Marisol Cano, Masashi Fujihara, Kanako Izumi-Nagai, Xiaoni Kong, Michael B. Sporn, Thomas W. Kensler, Shyam Biswal, James T. Handa

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Uveitis is an inflammatory condition that can lead to blindness. It is therefore important to understand the pathophysiology against which to develop targeted therapy. Herein, we tested whether the oxidant-responsive transcription factor Nrf2 is involved in regulating the innate immune response and oxidative damage in the LPS uveitis model. As shown by dihydroethidium staining, intraperitoneally injected LPS increased reactive oxygen species in the retina and iris-ciliary body of Nrf2+/+ and Nrf2-/- mice. After LPS injection, ICAM-1, IL-6, TNF-α, COX-2, iNOS, and MCP-1 mRNAs were increased more in the retina and iris-ciliary body of Nrf2-/- than in those of Nrf2+/+ mice. NQO-1 and GCLM, two Nrf2-responsive antioxidant enzymes, had reduced expression in Nrf2+/+ retinas after LPS injection, but no change in expression in Nrf2-/- mice. The number of FITC-Con A-labeled leukocytes adherent to the retinal vascular endothelium increased after LPS treatment in both Nrf2+/+ and Nrf2-/- mice compared to control injections, with more adherent leukocytes in Nrf2-/- than in Nrf2+/+ mice. Pretreatment with the Nrf2 activator 1-(2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl)imidazole increased antioxidant gene expression in the retina, reduced inflammatory mediator expression, and reduced leukocyte adherence to retinal vasculature after LPS treatment in Nrf2+/+ mice, but had no effect on Nrf2-/- mice. Treatment targeting the Nrf2 pathway may be a new therapy for uveitis.

Original languageEnglish
Pages (from-to)300-306
Number of pages7
JournalFree Radical Biology and Medicine
Volume47
Issue number3
DOIs
Publication statusPublished - 2009 Aug 1
Externally publishedYes

Fingerprint

Uveitis
Innate Immunity
Modulators
Antioxidants
Intercellular Adhesion Molecule-1
Retina
Oxidants
Gene expression
Interleukin-6
Reactive Oxygen Species
Transcription Factors
Ciliary Body
Leukocytes
Messenger RNA
Iris
Enzymes
Injections
Therapeutics
Retinal Vessels
Vascular Endothelium

Keywords

  • Adhesion molecules
  • Cytokines
  • Free radicals
  • Lipopolysaccharide
  • Nuclear factor erythroid-2 related factor 2
  • Rodent
  • Transcription factors
  • Transgenic/knockout mice
  • Triterpenoids
  • Uveitis

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Nagai, N., Thimmulappa, R. K., Cano, M., Fujihara, M., Izumi-Nagai, K., Kong, X., ... Handa, J. T. (2009). Nrf2 is a critical modulator of the innate immune response in a model of uveitis. Free Radical Biology and Medicine, 47(3), 300-306. https://doi.org/10.1016/j.freeradbiomed.2009.04.033

Nrf2 is a critical modulator of the innate immune response in a model of uveitis. / Nagai, Norihiro; Thimmulappa, Rajesh K.; Cano, Marisol; Fujihara, Masashi; Izumi-Nagai, Kanako; Kong, Xiaoni; Sporn, Michael B.; Kensler, Thomas W.; Biswal, Shyam; Handa, James T.

In: Free Radical Biology and Medicine, Vol. 47, No. 3, 01.08.2009, p. 300-306.

Research output: Contribution to journalArticle

Nagai, N, Thimmulappa, RK, Cano, M, Fujihara, M, Izumi-Nagai, K, Kong, X, Sporn, MB, Kensler, TW, Biswal, S & Handa, JT 2009, 'Nrf2 is a critical modulator of the innate immune response in a model of uveitis', Free Radical Biology and Medicine, vol. 47, no. 3, pp. 300-306. https://doi.org/10.1016/j.freeradbiomed.2009.04.033
Nagai, Norihiro ; Thimmulappa, Rajesh K. ; Cano, Marisol ; Fujihara, Masashi ; Izumi-Nagai, Kanako ; Kong, Xiaoni ; Sporn, Michael B. ; Kensler, Thomas W. ; Biswal, Shyam ; Handa, James T. / Nrf2 is a critical modulator of the innate immune response in a model of uveitis. In: Free Radical Biology and Medicine. 2009 ; Vol. 47, No. 3. pp. 300-306.
@article{c1d29bb7ab9f4d4592945f7346b684cc,
title = "Nrf2 is a critical modulator of the innate immune response in a model of uveitis",
abstract = "Uveitis is an inflammatory condition that can lead to blindness. It is therefore important to understand the pathophysiology against which to develop targeted therapy. Herein, we tested whether the oxidant-responsive transcription factor Nrf2 is involved in regulating the innate immune response and oxidative damage in the LPS uveitis model. As shown by dihydroethidium staining, intraperitoneally injected LPS increased reactive oxygen species in the retina and iris-ciliary body of Nrf2+/+ and Nrf2-/- mice. After LPS injection, ICAM-1, IL-6, TNF-α, COX-2, iNOS, and MCP-1 mRNAs were increased more in the retina and iris-ciliary body of Nrf2-/- than in those of Nrf2+/+ mice. NQO-1 and GCLM, two Nrf2-responsive antioxidant enzymes, had reduced expression in Nrf2+/+ retinas after LPS injection, but no change in expression in Nrf2-/- mice. The number of FITC-Con A-labeled leukocytes adherent to the retinal vascular endothelium increased after LPS treatment in both Nrf2+/+ and Nrf2-/- mice compared to control injections, with more adherent leukocytes in Nrf2-/- than in Nrf2+/+ mice. Pretreatment with the Nrf2 activator 1-(2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl)imidazole increased antioxidant gene expression in the retina, reduced inflammatory mediator expression, and reduced leukocyte adherence to retinal vasculature after LPS treatment in Nrf2+/+ mice, but had no effect on Nrf2-/- mice. Treatment targeting the Nrf2 pathway may be a new therapy for uveitis.",
keywords = "Adhesion molecules, Cytokines, Free radicals, Lipopolysaccharide, Nuclear factor erythroid-2 related factor 2, Rodent, Transcription factors, Transgenic/knockout mice, Triterpenoids, Uveitis",
author = "Norihiro Nagai and Thimmulappa, {Rajesh K.} and Marisol Cano and Masashi Fujihara and Kanako Izumi-Nagai and Xiaoni Kong and Sporn, {Michael B.} and Kensler, {Thomas W.} and Shyam Biswal and Handa, {James T.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1016/j.freeradbiomed.2009.04.033",
language = "English",
volume = "47",
pages = "300--306",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Nrf2 is a critical modulator of the innate immune response in a model of uveitis

AU - Nagai, Norihiro

AU - Thimmulappa, Rajesh K.

AU - Cano, Marisol

AU - Fujihara, Masashi

AU - Izumi-Nagai, Kanako

AU - Kong, Xiaoni

AU - Sporn, Michael B.

AU - Kensler, Thomas W.

AU - Biswal, Shyam

AU - Handa, James T.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Uveitis is an inflammatory condition that can lead to blindness. It is therefore important to understand the pathophysiology against which to develop targeted therapy. Herein, we tested whether the oxidant-responsive transcription factor Nrf2 is involved in regulating the innate immune response and oxidative damage in the LPS uveitis model. As shown by dihydroethidium staining, intraperitoneally injected LPS increased reactive oxygen species in the retina and iris-ciliary body of Nrf2+/+ and Nrf2-/- mice. After LPS injection, ICAM-1, IL-6, TNF-α, COX-2, iNOS, and MCP-1 mRNAs were increased more in the retina and iris-ciliary body of Nrf2-/- than in those of Nrf2+/+ mice. NQO-1 and GCLM, two Nrf2-responsive antioxidant enzymes, had reduced expression in Nrf2+/+ retinas after LPS injection, but no change in expression in Nrf2-/- mice. The number of FITC-Con A-labeled leukocytes adherent to the retinal vascular endothelium increased after LPS treatment in both Nrf2+/+ and Nrf2-/- mice compared to control injections, with more adherent leukocytes in Nrf2-/- than in Nrf2+/+ mice. Pretreatment with the Nrf2 activator 1-(2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl)imidazole increased antioxidant gene expression in the retina, reduced inflammatory mediator expression, and reduced leukocyte adherence to retinal vasculature after LPS treatment in Nrf2+/+ mice, but had no effect on Nrf2-/- mice. Treatment targeting the Nrf2 pathway may be a new therapy for uveitis.

AB - Uveitis is an inflammatory condition that can lead to blindness. It is therefore important to understand the pathophysiology against which to develop targeted therapy. Herein, we tested whether the oxidant-responsive transcription factor Nrf2 is involved in regulating the innate immune response and oxidative damage in the LPS uveitis model. As shown by dihydroethidium staining, intraperitoneally injected LPS increased reactive oxygen species in the retina and iris-ciliary body of Nrf2+/+ and Nrf2-/- mice. After LPS injection, ICAM-1, IL-6, TNF-α, COX-2, iNOS, and MCP-1 mRNAs were increased more in the retina and iris-ciliary body of Nrf2-/- than in those of Nrf2+/+ mice. NQO-1 and GCLM, two Nrf2-responsive antioxidant enzymes, had reduced expression in Nrf2+/+ retinas after LPS injection, but no change in expression in Nrf2-/- mice. The number of FITC-Con A-labeled leukocytes adherent to the retinal vascular endothelium increased after LPS treatment in both Nrf2+/+ and Nrf2-/- mice compared to control injections, with more adherent leukocytes in Nrf2-/- than in Nrf2+/+ mice. Pretreatment with the Nrf2 activator 1-(2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl)imidazole increased antioxidant gene expression in the retina, reduced inflammatory mediator expression, and reduced leukocyte adherence to retinal vasculature after LPS treatment in Nrf2+/+ mice, but had no effect on Nrf2-/- mice. Treatment targeting the Nrf2 pathway may be a new therapy for uveitis.

KW - Adhesion molecules

KW - Cytokines

KW - Free radicals

KW - Lipopolysaccharide

KW - Nuclear factor erythroid-2 related factor 2

KW - Rodent

KW - Transcription factors

KW - Transgenic/knockout mice

KW - Triterpenoids

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=67349238218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349238218&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2009.04.033

DO - 10.1016/j.freeradbiomed.2009.04.033

M3 - Article

VL - 47

SP - 300

EP - 306

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 3

ER -